Korean J Urol. 2007 Mar;48(3):348-351. Korean.
Published online Mar 31, 2007.
Copyright © 2007 The Korean Urological Association
Case Report

Male Patients with the Diagnoses of Synchronous Prostate and Breast Cancer

Chang Yell Lee, Chang Soo Park, Wan Lee, Hee Suk Kwak,1 Mee Young Sol,2 and Moon Kee Chung
    • Department of Urology, Pusan National University College of Medicine, Busan, Korea.
    • 1Department of General Surgery, Pusan National University College of Medicine, Busan, Korea.
    • 2Department of Pathology, Pusan National University College of Medicine, Busan, Korea.
Received October 30, 2006; Accepted January 21, 2007.

Abstract

Prostate cancer and male breast cancer are similar in many ways, including the potential role of steroidal hormones in their pathogenesis and shared genetic abnormalities. However, the combination of these cancers in the same patient is rare. Herein, the case of a male patient, diagnosed with synchronous prostate and breast cancers, is reported.

Keywords
Synchronous neoplasms; Prostate cancer; Breast cancer

Figures

Fig. 1
(A) The tumor cell nests forming a solid mass, with pushing margin infiltrates into normal breast parenchyma (H&E, ×100). (B) The tumor cells are large, with prominent nucleoli (H&E, ×400).

Fig. 2
Immunohistochemical staining for the prostate-specific antigen (PSA) (A) and prostate associated protein antigen (PAP) (B) showing negative reactions in a breast ductal carcinoma.

Fig. 3
(A) The small compact tumor cell nests infiltrating into the normal prostatic parenchyma (H&E, ×200). (B) The tumor cells have prominent basophilic nucleoli, which are characteristic of a prostatic adenocarcinoma (H&E, ×400).

Fig. 4
Immunohistochemical staining for the prostate-specific antigen (PSA) (A) and prostate associated protein antigen (PAP) (B) showing positive reactions.

Tables

Table 1
Treatment of patients with male breast cancer and prostate cancer

References

    1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics,2002. CA Cancer J Clin 2002;52:23–47.
    1. Lopez-Otin C, Diamandis EP. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev 1998;19:365–396.
    1. Ozet A, Yavuz AA, Komurcu S, Ozturk B, Safali M, Arpaci F, et al. Bilateral male breast cancer and prostate cancer: a case report. Jpn J Clin Oncol 2000;30:188–190.
    1. Leibowitz SB, Garber JE, Fox EA, Loda M, Kaufman DS, Kantoff PW, et al. Male patients with diagnoses of both breast cancer and prostate cancer. Breast J 2003;9:208–212.
    1. Karlsson CT, Malmer B, Wiklund F, Gronberg H. Breast cancer as a second primary in patients with prostate cancer--estrogen treatment or association with family history of cancer? J Urol 2006;176:538–543.
    1. Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjord JE, et al. BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 1997;75:758–761.
    1. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53:538–549.
    1. Diez O, Cortes J, Domenech M, Pericay C, Brunet J, Alonso C, et al. BRCA2 germ-line mutations in Spanish male breast cancer patients. Ann Oncol 2000;11:81–84.
    1. Valeri A, Fournier G, Morin V, Morin JF, Drelon E, Mangin P, et al. Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int J Cancer 2000;86:883–887.
    1. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999;91:1310–1316.

Metrics
Share
Figures

1 / 4

Tables

1 / 1

PERMALINK